Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Patient- and donor-dependent factors in descemet membrane endothelial keratoplasty and their impact on visual acuity and quality of life].

Die Ophthalmologie·2025
Same author

[Endogenous Candida endophthalmitis: diagnostics and treatment options based on case studies].

Die Ophthalmologie·2024
Same author

[Endogenous Candida endophthalmitis].

Die Ophthalmologie·2024
Same author

[Orbitofacial manifestation of sarcoidosis].

Die Ophthalmologie·2022
Same author

[Bilateral idiopathic orbital inflammation with chronic sinusitis-an IgG4-related disease?]

Die Ophthalmologie·2022
Same author

[Prophylactic intubation of the lacrimal duct in chemoradiotherapy of the lacrimal sac].

Die Ophthalmologie·2021

Related Experiment Video

Updated: Jun 27, 2026

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis
07:24

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis

Published on: February 6, 2021

[Traumatic Endophthalmitis Prevention Trial (TEPT)].

A Viestenz1, W Schrader, W Behrens-Baumann

  • 1Univ.-Augenklinik, Otto-von-Guericke-Universität, Magdeburg. dr.arne.viestenz@t-online.de

Klinische Monatsblatter Fur Augenheilkunde
|November 19, 2008
PubMed
Summary
This summary is machine-generated.

This study investigates if adding an intravitreal antibiotic injection to intravenous antibiotics can prevent post-traumatic endophthalmitis after severe eye injuries. Results will compare infection rates between treatment groups.

Related Experiment Videos

Last Updated: Jun 27, 2026

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis
07:24

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis

Published on: February 6, 2021

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Trauma Surgery

Background:

  • Post-traumatic endophthalmitis is a severe complication of open globe injuries, occurring in 2-17% of cases.
  • Early intravenous antibiotics are crucial for minimizing this risk.
  • The efficacy of additional intravitreal antibiotics in prevention remains to be fully elucidated.

Purpose of the Study:

  • To design and present a study evaluating the role of an additional intravitreal antibiotic injection in preventing post-traumatic endophthalmitis.
  • To compare the effectiveness of intravenous antibiotics alone versus combined intravenous and intravitreal antibiotics.

Main Methods:

  • A prospective, multicentre, randomised controlled study design.
  • Inclusion of patients with penetrating or perforating eye injuries treated within 24 hours.
  • Randomization into two groups: intravenous moxifloxacin alone, or intravenous moxifloxacin plus intravitreal Vancomycin and Ceftazidim.

Main Results:

  • Seventeen European Ophthalmology Departments are participating.
  • Statistical comparison of post-traumatic endophthalmitis rates between the two treatment arms.
  • A 6-month follow-up period is planned for all participants.

Conclusions:

  • The study aims to provide evidence-based recommendations for the prevention of post-traumatic endophthalmitis.
  • Further participation in the TEPT study is encouraged from other ophthalmology departments.